268JPY
20.34 BJPY
173.46 BJPY
43.09 M
About KOBAYASHI PHARMACEUTICALS
Sector
Headquarters
Osaka
Employees (FY)
3.53 K
Website
Founded
1886
ISIN
JP3301100008
FIGI
BBG000BSYMV5
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4967 is 5614 JPY — it has decreased by 1.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange KOBAYASHI PHARMACEUTICALS stocks are traded under the ticker 4967.
KOBAYASHI PHARMACEUTICALS is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4967 stock is 2.23% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is KOBAYASHI PHARMACEUTICALS there?
4967 earnings for the last quarter are 100.29 JPY per share, whereas the estimation was 88.94 JPY resulting in a 12.77% surprise. The estimated earnings for the next quarter are 56.55 JPY per share. See more details about KOBAYASHI PHARMACEUTICALS earnings.
KOBAYASHI PHARMACEUTICALS revenue for the last quarter amounts to 45.49 B JPY despite the estimated figure of 45.05 B JPY. In the next quarter revenue is expected to reach 54.74 B JPY.
Yes, you can track KOBAYASHI PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
4967 stock has fallen by 0.64% compared to the previous week, the month change is a 11.04% rise, over the last year KOBAYASHI PHARMACEUTICALS has showed a 33.95% decrease.
4967 net income for the last quarter is 4.84 B JPY, while the quarter before that showed 7.63 B JPY of net income which accounts for −36.63% change. Track more KOBAYASHI PHARMACEUTICALS financial stats to get the full picture.
Today KOBAYASHI PHARMACEUTICALS has the market capitalization of 422.10 B, it has increased by 1.42% over the last week.
KOBAYASHI PHARMACEUTICALS dividend yield was 1.49% in 2023, and payout ratio reached 37.66%. The year before the numbers were 1.00% and 34.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4967 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOBAYASHI PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 3.53 K employees. See our rating of the largest employees — is KOBAYASHI PHARMACEUTICALS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOBAYASHI PHARMACEUTICALS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOBAYASHI PHARMACEUTICALS stock shows the sell signal. See more of KOBAYASHI PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KOBAYASHI PHARMACEUTICALS future price: according to them, 4967 price has a max estimate of 10400.00 JPY and a min estimate of 6540.00 JPY. Read a more detailed KOBAYASHI PHARMACEUTICALS forecast: see what analysts think of KOBAYASHI PHARMACEUTICALS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOBAYASHI PHARMACEUTICALS EBITDA is 31.84 B JPY, and current EBITDA margin is 18.36%. See more stats in KOBAYASHI PHARMACEUTICALS financial statements.